Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease

Journal of Virology

Volumn 75, Issue 5, 2001, Pages 2262-2275

  Broussard, S R ^a   Staprans, S I ^a   White, R ^a   Whitehead, E M ^a   Feinberg, M B ^a   Allan, J S ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL LINE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA DETERMINATION; GASTROINTESTINAL TRACT; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPATHOLOGY; LYMPH NODE; MONKEY; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VIROGENESIS; VIRUS INFECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; BRAIN; CERCOPITHECUS AETHIOPS; CEREBROSPINAL FLUID; GENE PRODUCTS, ENV; HUMANS; IMMUNITY, NATURAL; LYMPHOID TISSUE; MACROPHAGES; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 0035121414     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.5.2262-2275.2001     Document Type: Article

References (96)

1. Receptor-mediated activation of the viral envelope and viral entry
2. Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys
3. Species-specific diversity among simian immunodeficiency viruses from African green monkeys
4. Enhancement of SIV infection with soluble receptor molecules
5. Viral burden and disease progression in HIV-1-infected patients with sickle cell anemia
6. HIV suppression by interleukin-16
7. Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host
8. Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys
9. Simian immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): Evidence for host-dependent evolution of SIV within the C. lhoesti superspecies
10. Genetic diversity of simian immunodeficiency viruses from West African green monkeys: Evidence of multiple genotypes within populations from the same geographical locale
11. Simian immunodeficiency virus infection in a patas monkey (Erythrocebus patas): Evidence for cross-species transmission from African green monkeys (Cercopithecus aethiops sabaeus) in the wild
12. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
13. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
14. Extensive envelope heterogeneity of simian immunodeficiency virus in tissues from infected macaques
15. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
16. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection
17. Genetic characterization of new West African simian immunodeficiency virus SIVsm: Geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop
18. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
19. The V3 domain of the HIV-1 gpl20 envelope glycoprotein is critical for chemokine-mediated blockade of infection
20. Levels of HIV-infected peripheral blood cells remain stable throughout the natural history of HIV-1 infection. Swiss HIV Cohort Study
21. Simian immunodeficiency virus from African green monkeys
22. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays
23. Expression cloning of new receptors used by simian and human immunodeficiency viruses
24. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys
25. Analysis of ENV V3 sequences from HIV-1-infected brain indicates restrained virus expression throughout the disease
26. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins
27. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources
28. CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine
29. Programmed cell death and AIDS: Significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections
30. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
31. A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey
32. Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group
33. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS
34. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
35. HIV infection and dementia
36. The role of mononuclear phagocytes in HTLV-III/LAV infection
37. Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm)
38. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression
39. Population biology of HIV-I infection: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues
40. AIDS as a zoonosis: Scientific and public health implications
41. Quantitation of a lentivirus in its natural host: Simian immunodeficiency virus in African green monkeys
42. CCR3 and CCR5 are co-receptors for HIV-1-infection of microglia
43. Characterization of a novel simian immunodeficiency virus (SIV) from l'hoest monkeys (Cercopithecus l'hoesti): Implications for the origins of SIVmnd and other primate lentiviruses
44. Phylogeny and natural history of the primate lentiviruses. SIV and HIV
45. Induction of AIDS by simian immunodeficiency virus from an African green monkey: Species-specific variation in pathogenicity correlates with the extent of in vivo replication
46. A distinct African lentivirus from Sykes' monkeys
47. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara
48. Identification of a new subgroup of SIVagm in tantalus monkeys
49. An African primate lentivirus (SIVsm) closely related to HIV-2
50. Simian immunodeficiency virus infection of macaques: End-stage disease is characterized by widespread distribution of proviral DNA in tissues
51. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1-infection
52. Mosaic genome structure of simian immunodeficiency virus from West African green monkeys
53. Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: Evidence for cross-species transmission in the wild
54. SIVagm incidence over two decades in a natural population of Ethiopian grivet monkeys (Cercopithecus aethiops aethiops)
55. Generation of diversity in retroviruses
56. Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques
57. Importance of the nef gene for the maintenance of high virus loads and for development of AIDS
58. Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line MOLT-4
59. Heterogeneity of HIV-1 and HIV-2
60. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences
61. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
62. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons
63. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor
64. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection
65. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase
66. Prognosis in HIV-1-infection predicted by the quantity of virus in plasma
67. High resolution analysis of HIV-1 quasispecies in the brain
68. The role of the V3 loop of gp120 in HIV infection
69. Simian immunodeficiency viruses from central and western Africa: Evidence for a new species-specific lentivirus in tantalus monkeys
70. The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo
71. CD4 and CD8 expressions in African green monkey helper T lymphocytes: Implication for resistance to SIV infection
72. mac
73. Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys
74. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection
75. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
76. Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon
77. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
78. Sexual transmission of SIVagm in wild grivet monkeys
79. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR
80. Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: Window into brain infection?
81. A role for carbohydrates in immune evasion in AIDS
82. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease
83. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120
84. Rates of amino acid change in the envelope protein correlate with pathogenicity of primate lentiviruses
85. Time course of cerebrospinal fluid responses to antiretroviral therapy: Evidence for variable compartmentalization of infection
86. Quantitative methods to monitor viral load in simian immunodeficiency virus infections
87. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection
88. Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology
89. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection
90. Specific tropism of HIV-1 for microglial cells in primary human brain cultures
91. Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival
92. Viral dynamics in human immunodeficiency virus type 1 infection
93. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro
94. Cell-associated HIV-RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study
95. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV
96. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis